Singh SK, Grifson JJ, Mavuduru RS, Agarwal MM, Mandal AK, Jha V.
SourceDepartment of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. shrawanksingh2002@yahoo.com
Abstract
INTRODUCTION: High expression of leptin receptors have been observed in the prostate cancer in various clinical studies; however the association of serum leptin with carcinoma prostate remains unresolved. We studied association, between serum leptin and carcinoma prostate in Asian (Indian) population and its association with obesity.
MATERIAL AND METHODS: 30 prospective cases of cancer prostate and 30 age matched controls were included in this study. Body mass index (BMI) was estimated and categorized in 4 groups by WHO criteria. Waist hip ratio (WHR) was calculated and divided into three groups. Serum leptin was estimated by sandwich ELISA technique (DRG leptin ELISA kit, Marburg, Germany).
RESULTS: Both the groups were comparable for age, WHR and BMI. Serum leptin was significantly higher in patients with cancer prostate as compared to controls (median 14.18 ng/ml vs. 1.63 ng/ml; p< 0.001). The level of leptin was found to have positive correlation with BMI and WHR in controls (r=0.485, p=0.007; r=0.314, p=0.091, respectively) however, no correlation was observed in patients with cancer prostate (r=0.071, p=0.711; r=0.067, p=0.725, respectively). There was no correlation between leptin and PSA. The serum leptin level was not related to the Gleason's score and stage of the carcinoma.
CONCLUSIONS: This study shows that Prostate cancer is associated with raised serum leptin which is independent of obesity and serum PSA. It hints the role of leptin in pathogenesis of this tumor. It may not be a surrogate marker of aggressiveness. For validation, further studies including a large patient population is required.
Cancer Biomark 2010;jun 1;7(1):11-5
·
Serum leptin: a marker of prostate cancer irrespective of obesity.
作者：北京經緯博恒生物科技開發有限責任公司 2011-05-10T00:00 (訪問量:30540)
北京經緯博恒生物科技開發有限責任公司 商家主頁
地 址： 北京市海淀區萬壽路街道太平路甲40號22樓411(軍醫科院南門).廊坊經濟技術開發區翠微南道29號(生產基地)
聯系人： 李經理
電 話： 業務：010-68167058，手機:18210299625
傳 真： 010-68167058
Email：genwaybh@163.com
相關咨詢
肝細胞癌中的Leptin (2011-06-13T00:00 瀏覽數:37466)
人和牛奶中的宿主防御蛋白 (2011-06-01T00:00 瀏覽數:36898)
乳腺癌病人組織中LEPTIN水平 (2011-05-24T00:00 瀏覽數:35584)
LEPTIN于膿毒癥中是一種危重病人適合的生物標志嗎? (2011-05-20T00:00 瀏覽數:37486)
乳鐵蛋白是II型糖尿病人患致死性心臟缺血的預警因子 (2011-05-16T00:00 瀏覽數:35114)
血清乳鐵蛋白水平是一種過敏性鼻炎的診斷指標 (2011-05-11T00:00 瀏覽數:76772)
Serum leptin: a marker of prostate cancer irrespective of obesity. (2011-05-10T00:00 瀏覽數:30540)
LEPTIN 是一種住院老年病人營養評估的有效生物指標 (2011-05-09T00:00 瀏覽數:33245)
Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis (2011-05-06T00:00 瀏覽數:25183)
血清瘦素質與心臟代謝危險相關 (2011-05-04T00:00 瀏覽數:35047)
ADVERTISEMENT